publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
letter
editor
chloroquin
paradox
may
caus
damag
help
fight
b
r
c
novel
coronaviru
diseas
pandem
recent
health
care
crisi
without
specif
prophylact
therapeut
drug
antimalari
drug
chloroquin
chl
safer
deriv
hydroxychloroquin
hchl
propos
repurpos
treat
sar
caus
agent
chlhchl
antiinflammatori
activ
use
treat
rheumatoid
arthriti
osteoarthr
lupu
although
chlhchl
antivir
activ
sever
virus
cellcultur
antivir
activ
invivo
question
repurpos
chlhchl
treat
infect
appeal
howev
empir
evid
anim
studi
virus
suggest
chlhchl
may
untoward
paradox
effect
one
thu
exclud
possibl
chl
may
increas
sever
diseas
prove
deleteri
patient
public
health
effort
contain
highli
contagi
explos
spread
novel
sever
acut
respiratori
syndrom
coronaviru
outbreak
reach
pandem
proport
frantic
search
effect
drug
recent
among
other
chloroquin
chl
safer
deriv
hydroxychloroquin
hchl
propel
drug
chl
inhibit
viru
cell
cultur
appear
reduc
viru
load
patient
open
label
nonrandom
trial
us
food
drug
administr
given
emerg
use
author
use
hchl
treatment
novel
coronaviru
diseas
chlhchl
excel
antivir
drug
invitro
increas
endosom
lysosom
ph
interfer
glycosyl
protein
acid
ph
endosom
lysosom
aid
viru
fusion
cell
well
releas
genet
materi
cell
initi
activ
viru
replic
modif
protein
glycosyl
includ
viral
envelop
protein
interfer
viru
assembl
releas
matur
viru
particl
inhibit
two
crucial
step
surpris
chlhchl
inde
found
effect
antivir
agent
invitro
includ
sarscov
fact
report
chlhchl
effect
antivir
agent
test
viru
cell
cultur
vitro
howev
invivo
chlhchl
shown
either
effect
viru
replic
increas
viral
replic
diseas
sever
influenza
dengu
semliki
forest
viru
sfv
encephalomyocard
viru
emcv
nipah
hendra
virus
chikungunya
viru
ebola
viru
clinic
trial
chl
treatment
fail
prevent
influenza
chikungunya
viru
infect
human
subject
suggest
increas
risk
infect
well
symptom
sever
children
treat
chl
follow
malari
infect
incid
herp
zoster
viru
hzv
markedli
enhanc
otherwis
common
children
similar
associ
later
report
adult
suggest
high
incid
hzv
dermatomyositispolymyosisti
patient
treat
chloroquin
treatment
plasmodium
infect
chlhchl
block
intraerythrocyt
stage
plasmodium
activ
hepat
stage
plasmodium
life
cycl
hepat
stage
sporozoit
plasmodium
caus
relaps
malaria
treat
quinolon
drug
mefloquin
primaquin
treatment
gammainterferon
ifng
alon
effect
exoerythrit
stage
plasmodium
cynomolgi
infect
monkey
prevent
relaps
parasitemia
howev
combin
chl
antisporozoit
activ
ifng
abolish
result
parasitemia
relaps
importantli
chl
shown
abolish
antivir
activ
ifn
mice
semliki
forest
viru
note
ifn
earliest
defens
respons
present
viru
infect
immunomodulatori
activ
chl
may
help
viru
infect
context
coronavirus
cov
caus
milder
diseas
human
protect
newborn
mice
human
induc
death
treatment
mother
mice
chl
shown
howev
newborn
presum
acquir
chl
transplacent
via
mother
milk
limit
extrapol
result
anticov
activ
direct
treatment
anim
chlhchl
sarscov
caus
sever
respiratori
syndrom
involv
lower
respiratori
tract
chl
show
antivir
activ
mice
due
antiinflammatori
activ
chlhchl
drug
use
treat
varieti
diseas
inflamm
central
diseas
pathogenesi
system
lupu
erythematosu
sle
rheumatoid
arthriti
ra
osteoarthr
caus
acut
inflamm
lung
condit
central
patholog
potenti
benefici
effect
chl
hchl
due
antiinflammatori
activ
postul
although
encourag
differ
treat
inflamm
vs
sle
ra
presenc
infecti
agent
ie
anim
studi
chl
enhanc
sever
inflammatori
viral
diseas
sfv
emcv
increas
arthrit
symptom
chikv
infect
patient
therefor
benefici
antiinflammatori
effect
chl
may
translat
infect
patient
care
plan
anim
studi
andor
clinic
trial
abl
answer
import
question
preliminari
find
nonrandom
openlabel
trial
show
reduct
viral
rna
load
hchl
hchl
combin
azithromycin
treatment
howev
hchl
treatment
start
patient
six
includ
final
analysi
drug
treatment
complet
patient
six
four
total
patient
patient
experienc
sever
includ
one
death
addit
anoth
patient
experienc
advers
effect
complet
trial
control
patient
experi
sever
form
advers
effect
hchl
treatment
patient
viru
titer
data
patient
progress
sever
diseas
treatment
hchl
avail
limit
abil
conclud
certainti
benefici
effect
hchl
potenti
exacerb
diseas
hchl
treatment
four
patient
rule
contradictori
result
protect
efficaci
chlhchl
patient
report
recent
clinic
report
trial
separ
studi
treatment
patient
hchl
combin
azithromycin
found
benefici
howev
direct
comparison
nondrug
treat
patient
made
although
patient
recov
three
hchl
treat
patient
progress
sever
diseas
includ
one
death
random
clinic
studi
patient
report
benefici
effect
hchl
treatment
compar
standard
clinic
care
contrast
small
cohort
studi
patient
found
protect
efficaci
hchl
azithromycin
patient
report
one
death
one
advers
effect
initi
hchl
treatment
progress
diseas
sever
hchl
treat
patient
also
observ
anoth
studi
otherwis
show
benefici
effect
hchl
treatment
prognosi
patient
paradox
studi
effect
chlhchl
viru
replic
particular
import
public
health
perspect
anim
studi
indic
chlhchl
increas
sever
virus
includ
inflamm
core
diseas
patholog
although
controversi
clinic
report
indic
benefici
effect
hchl
progress
diseas
sever
hchl
treat
pateint
nondrug
treat
patient
also
observ
studi
cautiou
thorough
review
antivir
activ
chlhchl
widespread
use
drug
treat
need
hasti
applic
chlhchl
treat
may
end
exacerb
diseas
increas
morbid
drawback
selfadministr
chl
hchl
highlight
overdos
toxic
fatal
outcom
selfadministr
chl
therefor
extrem
caution
need
extrapol
antivir
activ
chlhchl
test
time
opinion
express
herewith
author
necessarili
repres
usuh
dod
unit
state
armi
navi
air
forc
author
declar
conflict
interest
